MYLAN LABORATORIES LT API QAD R&D CENTER

MYLAN LABORATORIES LT API QAD R&D CENTER is an R&D center affiliated with a factory.

Company Introduction:

MYLAN LABORATORIES LT API QAD R&D CENTER in India is a dedicated Research and Development facility primarily focused on Active Pharmaceutical Ingredients (APIs). This center plays a critical role in the pharmaceutical manufacturing process by developing new APIs, optimizing existing API production methods, and ensuring stringent Quality Assurance Department (QAD) standards. As part of Mylan Laboratories, which is now a part of Viatris, it directly supports the company's manufacturing operations by innovating and refining the core components of pharmaceutical products. Its activities are integral to the production and quality control of various drugs, making it an essential component of a pharmaceutical manufacturing enterprise rather than a trading entity.

Mylan Laboratories Ltd., based in India and now part of Viatris, manufactures and sells a broad portfolio of products. Their API QAD R&D Center indicates significant involvement in the development and quality assurance of active pharmaceutical ingredients.

The products manufactured or sold include:

Active Pharmaceutical Ingredients (APIs)

These are the foundational chemical components used to produce finished pharmaceutical products across numerous therapeutic categories.

Finished Pharmaceutical Products (Generics and Specialty Pharmaceuticals)

The company produces and distributes a wide range of generic and specialty medicines, often based on the APIs they develop and manufacture. Key therapeutic areas and examples include:

Antiretrovirals

Medicines for the treatment of HIV/AIDS, such as fixed-dose combinations containing drugs like Dolutegravir, Tenofovir, Lamivudine, and Efavirenz.

Oncology

Treatments for various cancers, including drugs like Capecitabine, Gemcitabine, and Paclitaxel.

Cardiovascular Health

Medications for heart conditions, hypertension, and high cholesterol, such as Atorvastatin, Amlodipine, and Valsartan.

Central Nervous System

Drugs for neurological and psychiatric disorders, including Gabapentin, Venlafaxine, and Quetiapine.

Gastrointestinal Disorders

Medicines for digestive health issues.

Respiratory Conditions

Treatments for asthma and chronic obstructive pulmonary disease (COPD), such as Salbutamol (Albuterol) and Fluticasone.

Dermatology

Topical and systemic treatments for skin conditions.

Biosimilars

Biologic medicines that are highly similar to an already approved original biologic product, such as biosimilar versions of Trastuzumab (e.g., Ogivri) and Etanercept (e.g., Nepexto).

Injectable Products

A range of sterile injectable medicines for hospital and clinical use.

Complex Generics

Generic versions of complex drug products, including those with specialized delivery systems.